SignatureFD’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
SignatureFD's ADMA Position: Q3 2026 in Review
SignatureFD increased its ADMA Biologics (ADMA) stake by 8.5% in Q3 2026, buying an estimated $2.81K and bringing the position to 3,896 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2097.
SignatureFD first reported a position in ADMA in Q3 2022 and has held it in 17 quarters since. The position peaked at $93.6K in Q3 2024. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- SignatureFD held 3,896 shares of ADMA Biologics worth $39.1K as of Q3 2026.
- SignatureFD bought 304 ADMA Biologics shares in Q3 2026, an estimated $2.81K.
- ADMA Biologics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2097 holding.
- SignatureFD first reported a position in ADMA Biologics in Q3 2022 and has held it in 17 quarters since.
- SignatureFD's ADMA Biologics position peaked at $93.6K in Q3 2024.
- 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.